In IDE knockout mouse models, insulin degradation in liver and brain tissues is reduced by approximately 58–72%, resulting in chronic hyperinsulinemia and significantly elevated Aβ levels in the brain [67]. The gene discussed is INS; the disease is hyperinsulinism.